Cost of Harvoni in 2025: Discounts and additional savings
In this article, we'll delve into the factors that influence the cost of Harvoni, a brand-name drug used to treat hepatitis C in adults and some children.
Harvoni, a combination of ledipasvir and sofosbuvir, is a crucial medication in the treatment of hepatitis C. However, its cost can vary significantly, depending on factors like treatment plan, insurance coverage, pharmacy, and savings program.
Without Insurance
The original U.S. list price for a 12-week Harvoni course is approximately $24,000, making it expensive and potentially limiting access. Patent protections lasting at least until 2029 delay generic competition, sustaining high costs.
Manufacturer programs like Gilead's Support Path may provide co-pay coupons covering up to 25% of out-of-pocket costs, but they exclude Medicare Part D and Medicaid patients, and free medication programs have been discontinued for some drugs.
With Insurance
Insurance plans play a significant role in determining the cost of Harvoni. The drug's placement in specific formulary tiers determines copayments or coinsurance, with coverage and cost-sharing depending on the benefit plan’s terms, deductible status, and whether the drug is obtained from retail, specialty, or mail-order pharmacies.
Plans may impose quantity limits, age/gender restrictions, or require prior authorization, impacting coverage eligibility and cost. Coverage can vary widely between private insurance, Medicaid, Medicare Part D, and specialized programs like VA or state ADAP; some programs offer more comprehensive coverage than others.
Cost Factors
The cost factors include the original high list price, patent exclusivity, insurance plan specifics (coverage, tier placement, cost-sharing), prior authorization requirements, availability of patient assistance programs, and the type of insurance coverage the patient has.
Without insurance, the full list price applies unless assistance programs mitigate cost. With insurance, out-of-pocket costs depend on plan formularies, deductibles, copays/coinsurance, and coverage restrictions.
Generic Harvoni
Harvoni is now available in a generic version, which may cost less than the brand-name drug. The cost of the 90 mg/400 mg strength of Harvoni compared to its other strengths depends on factors like insurance coverage, pharmacy, and savings program.
The generic 90 mg ledipasvir/400 mg sofosbuvir tablets may cost less than the brand-name Harvoni tablets.
Support Path
For those seeking financial support and eligibility information, a program called Support Path is available. Their phone number is 855-769-7284, and their website can be found online.
Cost Comparison
The cost comparison of Harvoni, Epclusa, and Sovaldi depends on various factors, including insurance coverage, specific prescription drug plan, pharmacy, and savings program.
In conclusion, understanding the cost of Harvoni requires considering multiple factors, and it's essential to consult with your doctor, pharmacist, or insurance provider to get accurate information.
Health insurance providers play a significant role in determining the out-of-pocket costs of Harvoni, with the drug's placement in specific formulary tiers affecting copayments or coinsurance.
The cost of Harvoni can vary widely depending on the type of insurance coverage a patient has, with private insurance, Medicaid, Medicare Part D, and specialized programs like VA or state ADAP providing varying levels of coverage.
The availability of patient assistance programs, such as Gilead's Support Path, may also influence the cost of Harvoni, offering co-pay coupons for up to 25% of out-of-pocket costs (excluding Medicare Part D and Medicaid patients).
